Altered hippocampal connectivity dynamics predicts memory performance in neuropsychiatric lupus: a resting-state fMRI study using cross-recurrence quantification analysisAnastasia Pentari, Nicholas Simos, George Tzagarakis, Antonios Kagialis, George Bertsias, Eleftherios Kavroulakis, Eirini Gratsia, Prodromos Sidiropoulos, Dimitrios T Boumpas, Efrosini Papadaki
3 July 2023
Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren’s syndrome and systemic sclerosisRama Andraos, Awais Ahmad, Per Eriksson, Örjan Dahlström, Lina Wirestam, Charlotte Dahle, Roger Hesselstrand, Anders A Bengtsson, Andreas Jönsen, Kristofer Andréasson, Christopher Sjöwall
29 December 2022
Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLEErik W Anderson, Ying Jin, Andrew Shih, Arnon Arazi, Sara Goodwin, Julien Roeser, Richard A Furie, Cynthia Aranow, Bruce Volpe, Betty Diamond, Meggan Mackay
16 November 2022
Urine proteomic insights from the belimumab in lupus nephritis trialEmma Weeding, Andrea Fava, Chandra Mohan, Laurence Magder, Daniel Goldman, Michelle Petri
27 September 2022
Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)John Conklin, Michael Golpanian, Alexis Engel, Peter Izmirly, H Michael Belmont, Thierry Dervieux, Jill P Buyon, Roberta Vezza Alexander
5 September 2022
Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic responseJan-Mou Lee, Ming-Huang Chen, Kai-Yuan Chou, Yee Chao, Ming-Han Chen, Chang-Youh Tsai
23 June 2022
Phenotypical changes and clinical significance of CD4/CD8 T cells in SLEShiwen Yuan, Yanting Zeng, Jiawei Li, Cuicui Wang, Weinian Li, Zhixiang He, Jinghua Ye, Fangfei Li, Yi Chen, Xiaojun Lin, Na Yu, Xiaoyan Cai
22 June 2022
Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trialStephen McDonald, Sean Yiu, Li Su, Caroline Gordon, Matt Truman, Laura Lisk, Neil Solomons, Ian N Bruce, , for the MASTERPLANS Consortium, Ian N Bruce, Katherine Payne, Mark Lunt, Niels Peek, Nophar GeifmanSee the full list of authors
31 May 2022
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosusSerena Fasano, Michele Iudici, Melania Alessia Coscia, Valentina Messiniti, Alessia Borgia, Rosella Tirri, Francesco Ciccia
24 March 2022
Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosusGuillermo Ruacho, Ronaldo Lira-Junior, Iva Gunnarsson, Elisabet Svenungsson, Elisabeth A Boström
4 March 2022